Clinical Trials
Monday, May 21st, 2012
Preliminary Findings Presented at Heart Rhythm Society’s Annual Scientific Meeting BOSTON–(BUSINESS WIRE): May 11, 2012 08:00 AM. Patients with the heart rhythm disorder atrial fibrillation (AFib) who received first-line catheter ablation treatment had a longer arrhythmia-free interval than patients receiving antiarrhythmic drugs, the standard first-line treatment. The preliminary findings were presented during a late-breaking session […]
Clinical Trials
Monday, May 21st, 2012
The Lancet: May 2, 2012. Previous studies have suggested that any benefits of folic acid-based therapy to lower serum homocysteine in prevention of cardiovascular events might be offset by concomitant use of antiplatelet therapy. We aimed to establish whether there is an interaction between antiplatelet therapy and the effects of folic acid-based homocysteine-lowering therapy on major […]
Therapies
Monday, May 21st, 2012
Nejm.org: May 17, 2012. This Journal feature begins with a case vignette highlighting a common clinical problem. Evidence supporting various strategies is then presented, followed by a review of formal guidelines, when they exist. The article ends with the authors’ clinical recommendations. Stage A 62-year-old woman is seen 1 week after an ischemic stroke. She had presented to […]
Therapies
Monday, May 21st, 2012
Get With the Guidelines-Stroke 2003–2010 Stroke.ahajournals.org: May 15, 2012. Background and Purpose—Secondary stroke prevention treatments vary in different regions of the US. We determined the degree to which guideline-recommended stroke treatments vary by region for patients treated at hospitals participating in a voluntary national quality improvement program, Get With The Guidelines-Stroke. Methods—Receipt of 8 guideline-recommended treatments […]
Therapies
Monday, May 21st, 2012
ScienceDaily (May 14, 2012) — Following a stroke, factors as varied as blood sugar, body temperature and position in bed can affect patient outcomes, Loyola University Medical Center researchers report. In a review article in the journalMedLink Neurology, first author Murray Flaster, MD, PhD and colleagues summarize the latest research on caring for ischemic stroke patients. (Most […]
Therapies
Monday, May 21st, 2012
Society of NeuroInterventional Surgery: May 13, 2012. Background and purpose Technological advances have helped to improve the efficiency of treating patients with large vessel occlusion in acute ischemic stroke. Unfortunately, the sequence of events prior to reperfusion may lead to significant treatment delays. This study sought to determine if high-volume (HV) centers were efficient at delivery […]
Atrial Fibrillation
Monday, May 21st, 2012
cpr.sagepub.com: May 15, 2012. Background: Atrial fibrillation (AF) is a common cardiac arrhythmia which increases morbidity and mortality. Identification of risk factors is therefore important. We examined the impact of palpitations and cardiovascular risk factors in prediction of AF (all types) and lone AF in a large population-based cohort. Design: We carried out a prospective population-based cohort […]
Atrial Fibrillation
Monday, May 21st, 2012
Cpr.sagepub.com: May 14, 2012. Background—Efforts to reduce radiation from cardiac computed tomography (CT) are essential. Using a prospectively triggered, high-pitch dual source CT (DSCT) protocol, we aim to determine the radiation dose and image quality (IQ) in patients undergoing pulmonary vein (PV) imaging. Methods and Results—In 94 patients (61±9 years, 71% male) who underwent 128-slice DSCT […]
Atrial Fibrillation
Monday, May 21st, 2012
This held true even though blacks had more risk factors for the condition than whites, study finds THURSDAY, May 10 (HealthDay News) — Even though they have more risk factors, black Africans are about half as likely as white Europeans to develop a heart rhythm disorder called atrial fibrillation, a new study says. Atrial fibrillation, […]
Atrial Fibrillation
Monday, May 21st, 2012
A Report From the Swedish Atrial Fibrillation Cohort Study Circ.ahajournals.org: April 18, 2012. Background—Known risk factors for bleeding during anticoagulant treatment are largely the same as those predicting thromboembolic events in patients with atrial fibrillation (AF). Our objective was to investigate how to maximize the likelihood of avoiding both stroke and bleeding. Methods and Results—All 182 […]
